MEETINGS - Conference exploring the Global Challenges for Biotechnology in Healthcare (UK) February 1999:
This article was originally published in Clinica
Executive Summary
A conference exploring the Global Challenges for Biotechnology in Healthcare will take place in Cranfield, Bedford, UK, on February 16. The meeting will discuss the future of the healthcare market and look at ways in which biotechnology companies are generating future financing in order to maintain their current growth rate, despite the current reluctance of institutional investors to be involved in this industry. Contact Helen Fielding at the Cranfield School of Management in the UK for more details. Tel: +44 1234 754 362. Fax: +44 1234 750 835.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.